Ninja Nerd

Send us Fan Mail
Ninja Nerds!
In this episode of the Ninja Nerd Podcast, Zach and Rob walk you through a high-yield, case-based approach to COVID-19, built exactly the way you need it for exams and real clinical decision-making. Using three core cases, we break down how to recognize the disease, build a systematic diagnostic approach, and most importantly, match treatment to severity so you know exactly what to do in the moment.
We start by building the clinical foundation with a patient presenting with early symptoms like fever, cough, and loss of taste. In this case, we walk through the pathophysiology of SARS-CoV-2, focusing on its spike protein binding to ACE2 receptors and how this explains the multisystem involvement seen in COVID. You will learn how infection progresses through distinct phases, from early viral replication to pulmonary disease and finally to the hyperinflammatory state that drives severe complications like acute respiratory distress syndrome and multiorgan failure.  
Next, we expand this framework by connecting pathophysiology to clinical complications. We break down why patients develop diffuse alveolar damage and refractory hypoxemia, as well as the hypercoagulable state that leads to deep vein thrombosis, pulmonary embolism, and stroke. We also highlight high-yield complications, including acute kidney injury, myocarditis, and long COVID, emphasizing the key clinical clues that help you recognize them quickly.  
From there, we shift into a systematic diagnostic approach using a high-risk patient with known exposure. You will learn how to choose between polymerase chain reaction testing and rapid antigen testing, when negative results require repeat testing, and how the physical exam becomes a critical tool for severity classification. We also walk through when to order laboratory studies and imaging, including inflammatory markers, coagulation studies, chest imaging, and arterial blood gases, and how each result directly informs clinical decision-making rather than just adding data.  
Finally, we bring everything together with a step-by-step treatment framework based on disease severity. Through a progression of cases, we show how to manage mild to moderate disease in high-risk outpatients with early antiviral therapy, how to treat severe disease with oxygen support, corticosteroids, antivirals, and anticoagulation, and how to escalate care in critical illness with advanced respiratory support and immunomodulators. We also cover key monitoring pitfalls, including drug interactions, hepatotoxicity, and complications of therapy.  
We close with a focused review of prevention strategies, including vaccine mechanisms and the role of pre-exposure prophylaxis in select immunocompromised patients, tying everything together into a practical framework you can use on exams and in the hospital.
Let’s get into it, Ninja Nerds!
Support the show

Send us Fan Mail
Ninja Nerds!
In this episode of the Ninja Nerd Podcast, Zach and Rob walk you through a high-yield, case-based approach to influenza that goes far beyond “just the flu.” Using real clinical scenarios, we break down how this virus operates, who it hits hardest, and how to quickly recognize when a routine case is about to turn into something much more dangerous.
We start with the foundation, understanding the viral structure and why influenza is so unpredictable. Through discussion of hemagglutinin and neuraminidase, along with their segmented RNA genome, we build the clinical logic behind antigenic drift and antigenic shift, and why these mechanisms drive seasonal outbreaks rather than global pandemics.  
Next, we bring in a high-risk patient, an older adult with chronic lung and cardiac disease presenting with fever, malaise, and myalgias. In this case, we walk through how to identify high-risk populations, when testing is necessary, and why influenza can rapidly destabilize underlying conditions such as chronic obstructive pulmonary disease and heart failure. We also break down when to order confirmatory testing and how to think through worsening respiratory status in a clinically meaningful way.  
From there, we proceed to one of the most important clinical decisions: differentiating primary influenza pneumonia from secondary bacterial pneumonia. Using imaging patterns, clinical timing, and disease progression, we show you how to recognize diffuse viral lung injury versus the classic biphasic crash seen with superimposed bacterial infections such as Streptococcus pneumoniae or methicillin-resistant Staphylococcus aureus.  
We then move into rapid-fire, high-yield complications that are frequently tested and often missed. Through classic presentations, we cover Reye syndrome in children, Guillain-Barré syndrome following infection, and influenza-associated rhabdomyolysis, emphasizing the mechanisms, key clinical clues, and the importance of early recognition.  
Finally, we close with a focused discussion on treatment and prevention. You will learn when to initiate antiviral therapy with neuraminidase inhibitors versus alternative agents, who benefits most from treatment, and how timing impacts outcomes. We also walk through vaccination strategies, including high-dose vaccines in older adults, contraindications to live attenuated vaccines, and approaches to post-exposure chemoprophylaxis in high-risk settings such as nursing homes.  
Let’s get into it, Ninja Nerds!
Support the show

Send us Fan Mail
Ninja Nerds!
In this episode of the Ninja Nerd Podcast, Zach and Rob break down tuberculosis as a high-yield clinical framework rather than a list of random facts, focusing on how tuberculosis is actually tested and managed on exams, wards, and in the intensive care unit.
We begin with the classic active tuberculosis presentation and the first move that matters most, immediate airborne isolation. We then walk through how to confirm the diagnosis using the appropriate sequence of tests, including sputum acid-fast smear, nucleic acid amplification testing, and sputum culture. From there, we build the full treatment approach with rifampin, isoniazid, pyrazinamide, and ethambutol, plus the standard duration, and then hit a major exam trap, when cavitation and a persistently positive two-month culture force you to extend therapy beyond the usual timeline.
Next, we run the toxicity gauntlet so you can spot and respond to the big adverse effects fast, including hepatitis patterns that require stopping the offending drugs, ethambutol optic neuritis with red-green color discrimination loss, isoniazid-related peripheral neuropathy that is preventable with pyridoxine, and pyrazinamide-associated hyperuricemia and gout. We also emphasize how to monitor patients during therapy and recognize when clinical or microbiologic nonresponse should trigger a reassessment for adherence issues, drug resistance, or an alternative diagnosis.
We then pivot to latent tuberculosis screening and management, using realistic healthcare-style scenarios to review purified protein derivative interpretation thresholds, the next step after chest radiography, and practical latent treatment regimens. We also clarify how to think about tuberculosis risk stratification for immunocompromised patients, close contacts, and individuals from high-prevalence regions, since these details often determine which tests you order and how aggressively you treat. Finally, we close with the high-stakes extrapulmonary complications, why corticosteroids matter in tuberculous meningitis and pericarditis, and a classic drug interaction in which rifampin can undermine warfarin's effectiveness.
Enjoy the podcast and support us below!
Support the show

Send us Fan Mail
Ninja Nerds!
In this episode of the Ninja Nerd Podcast, Zach and Rob break down upper respiratory tract infections using a simple, case-based approach that always starts the same way: decide if the patient is unstable. We define instability as the presence of bedside red flags such as stridor, hypoxia, drooling, tripod positioning, muffled voice, trismus, severe neck swelling, or hemodynamic instability. If any are present, airway management takes priority and imaging waits. If the patient is stable, the next step is to localize the lesion to the nose and sinuses, the throat, or the larynx.
We then move through the most common upper respiratory presentations. The common cold is managed only with supportive care. Rhinosinusitis is classified as viral or bacterial based on time course: viral disease improves within 10 days, whereas bacterial disease persists or worsens after initial improvement and is treated with amoxicillin-clavulanate. Tonsillopharyngitis is approached with targeted testing for Group A streptococcus using rapid antigen testing, with culture follow-up in children and teens if negative, and appropriate antibiotic treatment to prevent complications. Epstein-Barr virus is considered an important alternative when fatigue and posterior cervical lymphadenopathy are prominent.
The episode then focuses on high-risk causes of stridor. Croup is identified by a barking cough and treated with dexamethasone, with racemic epinephrine added for more severe disease. Epiglottitis is characterized by the absence of cough and the presence of fever, drooling, tripod positioning, a muffled voice, and inspiratory stridor, with airway-first management and intravenous antibiotics and steroids.
We close by reviewing downstream complications, including acute otitis media following a viral illness and dangerous deep neck infections signaled by trismus, muffled voice, drooling, and neck pain, reinforcing the need for early airway assessment and timely imaging when indicated.
Enjoy the podcast, and please support us below!
Support the show

Send us Fan Mail
Ninja Nerds!
In this episode of the Ninja Nerd Podcast, Zach and Rob tackle laryngeal infections, a high-risk group of conditions where the key challenge is recognizing impending airway compromise rather than simply choosing an antibiotic. The episode is built around a case-based algorithm that helps listeners rapidly sort benign hoarseness from life-threatening obstruction.
The discussion begins with acute laryngitis, emphasizing hoarseness after a viral upper respiratory infection, lack of stridor, and why supportive care is appropriate. From there, the episode moves into viral croup, highlighting the classic barking cough, hoarseness, biphasic stridor, and nocturnal worsening. Zach and Rob review severity assessment, universal steroid use, when to add racemic epinephrine, and the critical observation window to monitor for rebound symptoms.
The conversation then escalates to epiglottitis, focusing on sudden onset of high fever, drooling, dysphagia, tripod positioning, and inspiratory stridor. They stress airway-first management, avoiding agitation, when imaging is appropriate, and definitive treatment with airway control, IV antibiotics, and steroids.
The episode closes with bacterial tracheitis, the dangerous scenario where presumed croup worsens and becomes toxic. Zach and Rob break down why racemic epinephrine fails, how thick purulent secretions cause mechanical airway obstruction, and why these patients often require intubation, IV antibiotics, and bronchoscopy.
The episode concludes with a rapid, high-yield comparison of laryngitis, croup, epiglottitis, and bacterial tracheitis to reinforce fast pattern recognition and airway-focused decision-making.
Enjoy the podcast, and please support us below!  
Support the show